Autolus Therapeutics (AUTL) Payables (2017 - 2026)
Autolus Therapeutics' (AUTL) quarterly Payables came in at $3.1 million in Q4 2025, up 56.58% YoY from $2.0 million in Q4 2024, and down 71.89% on a QoQ basis from $11.0 million in Q3 2025.
Autolus Therapeutics (AUTL) Payables (2017 - 2026) Analysis & Trends
Autolus Therapeutics (AUTL) has 9 years of Payables data on file, last reported at $3.1 million in Q4 2025.
- Quarterly Payables rose 56.58% year-over-year to $3.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $3.1 million (up 56.58% YoY) and the FY2025 annual result came in at $3.1 million, up 56.58% from the prior year.
- Payables retreated to $3.1 million in Q4 2025, from $11.0 million in the prior quarter.
- In the past five years, Payables ranged from a high of $11.0 million in Q3 2025 to a low of $103000.0 in Q4 2023.
- A 5-year average of $2.1 million and a median of $1.3 million in 2021 frame the typical range for Payables.
- Annual changes were most pronounced in 2022 — Payables plunged 93.23% — and 2023, when it soared 2293.83%.
- Tracing AUTL's Payables over 5 years: stood at $431000.0 in 2021, then rose by 23.2% to $531000.0 in 2022, then sank by 80.6% to $103000.0 in 2023, then soared by 1811.65% to $2.0 million in 2024, then soared by 56.58% to $3.1 million in 2025.
- The last three Payables figures came in at $3.1 million (Q4 2025), $11.0 million (Q3 2025), and $5.4 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Autolus Therapeutics | 763.37 Mn | 561.74 Mn | 25.22 Mn | 1.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.37 Mn |
| Dec 31, 2025 | 3.08 Mn |
| Sep 30, 2025 | 10.97 Mn |
| Jun 30, 2025 | 5.41 Mn |
| Mar 31, 2025 | 4.46 Mn |
| Dec 31, 2024 | 1.97 Mn |
| Sep 30, 2024 | 1.42 Mn |
| Jun 30, 2024 | 1.10 Mn |
| Mar 31, 2024 | 1.40 Mn |
| Dec 31, 2023 | 103,000.00 |
| Sep 30, 2023 | 661,000.00 |
| Jun 30, 2023 | 3.88 Mn |
| Mar 31, 2023 | 353,000.00 |
| Dec 31, 2022 | 531,000.00 |
| Sep 30, 2022 | 334,000.00 |
| Jun 30, 2022 | 162,000.00 |
| Mar 31, 2022 | 153,000.00 |
| Dec 31, 2021 | 431,000.00 |
| Sep 30, 2021 | 1.46 Mn |
| Jun 30, 2021 | 1.12 Mn |